To confirm the role of IL-17 of CD4+ T cells in induction of IL-32 expression in FLSs, the IL-17-rich supernatant from Th17-polarized cells was added to FLSs from RA patients. The gene discussed is IL17A; the disease is rheumatoid arthritis.